Livzon Group Fuzhou Fuxing Pharmaceutical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

A pharma company developing small molecules and biologics, with a focus on infectious diseases.

Infectious DiseaseOncologyOther (as part of broader group)

Integrated capabilities in synthetic chemistry and bioprocessing for developing and manufacturing small molecules and biologics.

Leveraging the parent group's resources to advance a novel drug candidate could provide a significant market advantage.

Heavy reliance on generic drug sales exposes the company to pricing pressures and volume-based procurement policies in China.

Faces intense competition in the generic drug market, especially for anti-infectives, and must navigate China's evolving drug pricing policies.